Sopharma AD-SofiaWAR:SPH 68 Interest Coverage is 12.81 as of Mar. 2026, which is 101% above its 10-year median of 6.36. GuruFocus rates WAR:SPH with a GF Score™ of 68/100 and a GF Value™ of zł12.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 89 Medical Distribution companies, Sopharma AD-Sofia ranks better than 56.18% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sopharma AD-Sofia's
Operating Income
for the
three
months ended in Mar. 2026 was zł139 Mil. Sopharma AD-Sofia's Interest Expense for the
three
months ended in Mar. 2026 was zł-11 Mil.
Sopharma AD-Sofia's interest coverage for the quarter that ended in Mar. 2026 was 12.81.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sopharma AD-Sofia's Interest Coverage or its related term are showing as below:
WAR:SPH'
s Interest Coverage Range Over the Past 10 Years
Min: 4.38 Med: 6.36 Max: 14.41
Current: 7.55
WAR:SPH's Interest Coverage is ranked better than 56.18% of 89
companies
in the Medical Distribution industry
Industry Median: 6.23
vs WAR:SPH: 7.55
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sopharma AD-Sofia Interest Coverage Related Terms
Sopharma AD-Sofia Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sopharma AD-Sofia's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
WAR:SPH vs MCK, COR, CAH: Interest Coverage Comparison
For the Medical Distribution subindustry, Sopharma AD-Sofia's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia (WAR:SPH) has a Interest Coverage of 12.81 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sopharma AD-Sofia and its competitors. This is 101% above median its historical median of 6.36. Over the past decade, Sopharma AD-Sofia's Interest Coverage has ranged from 4.38 to 14.41. According to the industry distribution chart, Sopharma AD-Sofia ranks #39 out of 89 companies in the Medical Distribution industry, placing it in the top 43.8%.
Is Sopharma AD-Sofia's Interest Coverage too high?
Sopharma AD-Sofia's current Interest Coverage of 12.81 is 101% above median its 10-year median of 6.36. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 14.41. The Medical Distribution industry median Interest Coverage is 6.23. Sopharma AD-Sofia's value of 12.81 is 105.6% above this industry median. Based on the distribution chart, Sopharma AD-Sofia ranks #39 out of 89 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sopharma AD-Sofia has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Interest Coverage compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sopharma AD-Sofia ranks #39 out of 89 companies for Interest Coverage. This puts Sopharma AD-Sofia in the upper half of its industry. The industry median Interest Coverage is 6.23. Sopharma AD-Sofia's value of 12.81 is 105.6% above this benchmark. Historically, Sopharma AD-Sofia's own Interest Coverage has ranged from 4.38 to 14.41 over the past decade. While the company's 10-year median is 6.36 vs. the industry median of 6.23, Sopharma AD-Sofia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma AD-Sofia's current Interest Coverage of 12.81 is 105.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sopharma AD-Sofia and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma AD-Sofia's current Interest Coverage is 12.81, which is 101% above median its own 10-year median of 6.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł12.97, compared to a current price of zł7.92 — trading 38.9% below its estimated fair value. The current Interest Coverage is 12.81, which is 101% above median its 10-year median of 6.36 and 105.6% above the Medical Distribution industry median of 6.23. Sopharma AD-Sofia's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current Interest Coverage is 12.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued.
The current stock price of zł7.92 is trading 38.9% below its estimated GF Value™ of zł12.97.
GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.
Key valuation signals for WAR:SPH:
Interest Coverage: 12.81 (101% above median its 10-year median of 6.36)
GF Value™: zł12.97 vs. price of zł7.92 (38.9% below fair value)
Industry Position: 105.6% above the Medical Distribution median (#39 of 89)
No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
68GF Score
Get the complete analysis for WAR:SPH
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SPH has been successfully added to your 
